Schedule 13D ownership disclosure
Silence Therapeutics plc
Security class unavailable · CUSIP: G8128Y157
Event date: 2022-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 24,281,709
- Percent of class
- 27.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-22-023327
- Form type
- SC 13D
- Filer
- Griffiths Richard Ian
- CIK
- CIK 1846370
- Filed
- Jun 15, 2022
- Reporting period
- Jun 08, 2022
- Description
- Schedule 13D beneficial ownership